GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:TPIV
Delisted

TapImmune Inc Fund Forecast

$8.34
+0 (+0%)
At Close: Oct 26, 2018
RSI low/high Values: [ 30 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

TapImmune Inc fund price down 0% on Friday
(Updated on Oct 26, 2018)

Sell candidate since Oct 10, 2018 Loss -3.47% PDF

No changes to the price of TapImmune Inc fund on the last trading day (Friday, 26th Oct 2018). During the last trading day the fund fluctuated 0% from a day low at $8.34 to a day high of $8.34. The price has been going up and down for this period, and there has been a 12.25% gain for the last 2 weeks.

The fund lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the fund is expected to rise 16.25% during the next 3 months and, with a 90% probability hold a price between $8.90 and $12.20 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TPIV Signals & Forecast

There are few to no technical positive signals at the moment. The TapImmune Inc fund holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.34 and $8.81. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, October 25, 2018, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for TapImmune Inc fund

TapImmune Inc finds support from accumulated volume at $8.26 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TPIV) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect TapImmune Inc to open at $8.34, and during the day (based on 14 day Average True Range), to move between $7.89 and $8.79, which gives a possible trading interval of +/-$0.447 (+/-5.36%) up or down from last closing price. If TapImmune Inc takes out the full calculated possible swing range there will be an estimated 10.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.26 (0.96%) than the resistance at $8.62 (3.36%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is TapImmune Inc fund A Buy?

The TapImmune Inc fund holds several negative signals and despite the positive trend, we believe TapImmune Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this fund.

Current score: -4.650 Sell Candidate Unchanged

Predicted Opening Price for TapImmune Inc of Monday, October 29, 2018

Fair opening price October 29, 2018 Current price
$8.34 ( 0%) $8.34

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TPIV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 8.34 .
R2 8.34 .
R1 8.34 .
Current price: 8.34
Support S1 8.34 .
S2 8.34 .
S3 8.34 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.95 19.30 %
R2 9.64 15.59 %
R1 8.62 3.36 %
Current price 8.34
Support S1 8.26 -0.96%
S2 7.88 -5.52%
S3 7.63 -8.51%

FAQ

What is the symbol for TapImmune Inc Fund and on which exchange is it traded?
The symbol for TapImmune Inc is TPIV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TapImmune Inc Fund?
The TapImmune Inc fund holds several negative signals and despite the positive trend, we believe TapImmune Inc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this fund.

How to buy TapImmune Inc Fund?
TapImmune Inc Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TapImmune Inc Fund.

What's the current price of TapImmune Inc Fund?
As of the end of day on the 2018-10-26, the price of an TapImmune Inc (TPIV) share was $8.34.

What is the 52-week high and low for TapImmune Inc Fund?
The 52-week high for TapImmune Inc Fund is $13.55 and the 52-week low is $2.58.
Click to get the best stock tips daily for free!

About TapImmune Inc

TapImmune, Inc., a clinical-stage immunotherapy company, develops peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer. The company, in collaboration with Mayo Foundation for Medical Education and Research, is developing HER2/neu+, a vaccine technology, which has completed Phase I human clinical trials for the treatment of breast cancer; and Folate Receptor Alpha, a peptide epitope, which has completed Phase I clinic... TPIV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT